INTRODUCTION: Ultrasound-guided thrombin injection (UGTI) is a well-established practice for the treatment of femoral artery pseudoaneurysm. This procedure is highly successful but dependent on appropriate pseudoaneurysm anatomy and adequate ultrasound visualization. Morbid obesity can present a significant technical challenge due to increased groin adiposity, resulting in poor visualization of critical structures needed to safely perform the procedure. We aim to evaluate the safety and efficacy of UGTI to treat femoral artery pseudoaneurysm in the morbidly obese. METHODS: This is a retrospective cohort study in which all patients who underwent UGTI at The Ohio State University Ross Heart Hospital from 2009 to 2014 were analyzed for patient characteristics and stratified by body mass index (BMI). Patients with BMI ≥ 35 were considered morbidly obese and were compared to patients with a BMI < 35. Outcome was failed treatment resulting in residual pseudoaneurysm. RESULTS: Our cohort consisted of 54 patients who underwent thrombin injection. There were 41 nonmorbidly obese and 13 morbidly obese patients. Mean age was 64.5 years. The cohort was 44.4% male. There were 6 failures, of which 1 underwent successful repeat injection and 5 underwent open surgical repair. There was no statistically significant difference in failure between nonmorbidly obese and morbidly obese patients (9.8% vs 15.4%, P = .45). There were no embolic/thrombotic complications. CONCLUSION: Ultrasound-guided thrombin injection is a safe and effective therapy in the morbidly obese for the treatment of femoral artery pseudoaneurysm. In the hands of experienced sonographers and surgeons with adequate visualization of the pseudoaneurysm sac, UGTI should remain a standard therapy in the morbidly obese.
INTRODUCTION: Ultrasound-guided thrombin injection (UGTI) is a well-established practice for the treatment of femoral artery pseudoaneurysm. This procedure is highly successful but dependent on appropriate pseudoaneurysm anatomy and adequate ultrasound visualization. Morbid obesity can present a significant technical challenge due to increased groin adiposity, resulting in poor visualization of critical structures needed to safely perform the procedure. We aim to evaluate the safety and efficacy of UGTI to treat femoral artery pseudoaneurysm in the morbidly obese. METHODS: This is a retrospective cohort study in which all patients who underwent UGTI at The Ohio State University Ross Heart Hospital from 2009 to 2014 were analyzed for patient characteristics and stratified by body mass index (BMI). Patients with BMI ≥ 35 were considered morbidly obese and were compared to patients with a BMI < 35. Outcome was failed treatment resulting in residual pseudoaneurysm. RESULTS: Our cohort consisted of 54 patients who underwent thrombin injection. There were 41 nonmorbidly obese and 13 morbidly obesepatients. Mean age was 64.5 years. The cohort was 44.4% male. There were 6 failures, of which 1 underwent successful repeat injection and 5 underwent open surgical repair. There was no statistically significant difference in failure between nonmorbidly obese and morbidly obesepatients (9.8% vs 15.4%, P = .45). There were no embolic/thrombotic complications. CONCLUSION: Ultrasound-guided thrombin injection is a safe and effective therapy in the morbidly obese for the treatment of femoral artery pseudoaneurysm. In the hands of experienced sonographers and surgeons with adequate visualization of the pseudoaneurysm sac, UGTI should remain a standard therapy in the morbidly obese.
Authors: Raul N Uppot; Dushyant V Sahani; Peter F Hahn; Mannudeep K Kalra; Sanjay S Saini; Peter R Mueller Journal: Radiology Date: 2006-06-26 Impact factor: 11.105
Authors: Jaime Gállego Pérez-Larraya; Pablo Irimia; Eduardo Martínez-Vila; Joaquín Barba; María Jesús Guembe; Nerea Varo; José María Castellano; José Javier Viñes; Javier Díez Journal: J Clin Ultrasound Date: 2012-04-17 Impact factor: 0.910
Authors: Wolfgang Mlekusch; Markus Haumer; Irene Mlekusch; Petra Dick; Sabine Steiner-Boeker; Andrea Bartok; Schila Sabeti; Markus Exner; Oswald Wagner; Erich Minar; Martin Schillinger Journal: Radiology Date: 2006-08 Impact factor: 11.105
Authors: Juraj Madaric; Augustin Mistrik; Ivan Vulev; Branislav Liska; Matej Vozar; Peter Lederer; Martin Gocar; Terezia Kozlovska; Viliam Fridrich; Bernard De Bruyne; Jozef Bartunek Journal: EuroIntervention Date: 2009-09 Impact factor: 6.534
Authors: Maria Gummerer; Moritz Kummann; Alexandra Gratl; Daniela Haller; Andreas Frech; Josef Klocker; Gustav Fraedrich; Hannes Gruber Journal: Vasc Endovascular Surg Date: 2020-06-19 Impact factor: 1.089
Authors: Hyoung-Ho Kim; Kyung-Wuk Kim; Changje Lee; Young Ho Choi; Min Uk Kim; Yasutaka Baba Journal: Korean J Radiol Date: 2021-07-26 Impact factor: 3.500